Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 HKD | +0.74% | +7.09% | -40.35% |
15/05 | Brii Bio's Hepatitis B Drugs Get Breakthrough Therapy Designation in China | MT |
25/03 | Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.35% | 13Cr | |
+8.63% | 12TCr | |
+13.17% | 11TCr | |
-12.76% | 2.23TCr | |
-3.99% | 2.16TCr | |
-7.19% | 1.82TCr | |
-39.93% | 1.76TCr | |
+6.67% | 1.43TCr | |
+33.90% | 1.24TCr | |
-28.60% | 828.11Cr |
- Stock Market
- Equities
- 2137 Stock
- News Brii Biosciences Limited
- UBS Adjusts Brii Biosciences’ Price Target to HK$26.40 From HK$26.50, Keeps at Buy